AliveCor QT Service vs AVIEW LCS

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by AliveCor
VS
by Coreline Soft

AI Verdict

Tool A specializes in real-time cardiac electrical safety by measuring QT/QTc intervals from ECGs, primarily informing medication prescribing decisions. Tool B, conversely, analyzes CT scans for lung cancer screening, COPD assessment, and coronary artery calcification scoring, offering a broader cardiopulmonary assessment from imaging data. While both contribute to cardiology, they address distinct clinical problems using different diagnostic modalities.

Choose AliveCor QT Service if…

Choose AliveCor QT Service if your primary need is rapid and precise assessment of cardiac QT intervals to mitigate drug-induced cardiac risk. This cloud-based SaMD is ideal for healthcare professionals who require instant, accurate QT and QTc measurements from AliveCor 6-Lead ECGs to inform critical medication prescribing decisions and enhance patient safety.

View AliveCor QT Service →

Choose AVIEW LCS if…

Choose AVIEW LCS if you require a comprehensive, AI-powered solution for integrated lung cancer screening and cardiopulmonary assessment from low-dose CT scans. This tool is best suited for radiologists and pulmonologists seeking automated detection and analysis of lung nodules, emphysema quantification, and coronary artery calcification scoring to streamline workflows and improve diagnostic accuracy.

View AVIEW LCS →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature AliveCor QT Service AVIEW LCS
Pricing Varies by product and service, with subscription options available. Subscription or one-off payment
Deployment Mobile app, cloud-based platform, EHR integration. Cloud-based, Hybrid solution, Locally on dedicated hardware, Locally virtualized (virtual machine, Docker)
BAA Available Yes AI-estimated Unknown
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

AVIEW LCS

AVIEW LCS is designed for seamless integration with PACS/RIS and generates comprehensive, automated reports for both clinicians and patients, including 3D visualization, which streamlines radiology workflows. While AliveCor QT Service emphasizes ease of use for its specific task and integrates with its own app/portal, some user reviews for associated AliveCor hardware indicate issues with reliability and customer support, which can impact overall user experience.

Clinical Value

AVIEW LCS

AVIEW LCS offers a broader and more comprehensive diagnostic assessment from a single low-dose CT scan, covering lung cancer screening, COPD, and coronary artery calcification with strong clinical validation for accuracy and workflow efficiency. It also provides automated follow-up comparisons for nodules, enhancing longitudinal patient management. While AliveCor QT Service provides crucial, time-sensitive cardiac safety data for medication management, Tool B's multi-disease screening offers a more expansive clinical utility.

Pricing & Value

AVIEW LCS

Both tools require direct contact with the vendor for pricing, making a transparent cost comparison impossible. However, AVIEW LCS's ability to perform a comprehensive 'Big 3' screening (lung cancer, COPD, and CAC) from a single CT scan suggests a higher potential for consolidating diagnostic efforts and providing greater overall value per scan compared to AliveCor QT Service's specialized QT interval measurement.

Enterprise Readiness

AVIEW LCS

AVIEW LCS offers superior deployment flexibility, including cloud, hybrid, local dedicated hardware, and virtualized environments, alongside explicit integration with standard radiology systems like PACS/RIS. While AliveCor QT Service provides API integration with various enterprise platforms, Tool B's broader deployment options and direct integration into established imaging workflows make it more adaptable and robust for diverse enterprise IT infrastructures.

Innovation

AVIEW LCS

AVIEW LCS demonstrates a higher degree of innovation by integrating AI for a comprehensive, multi-disease assessment (lung cancer, COPD, CAC) from a single CT scan, including automated follow-up comparisons. This holistic approach to screening and longitudinal tracking offers a broader and more transformative impact on radiology workflows and patient management. AliveCor QT Service's innovation is focused on instant, accurate QT measurements from ambulatory ECGs, which is valuable but more specialized.

Support & Docs

Tie

The provided structured facts and web search results do not offer sufficient specific details regarding the support services or documentation for either tool to make a definitive distinction. While AliveCor has a 'Resource Hub' with publications, some user reviews for their broader product line mention challenges with customer support. Without comparable information for AVIEW LCS, it is not possible to confidently pick a winner.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature AliveCor QT Service AVIEW LCS
Tool Name AliveCor QT Service AVIEW LCS
Company AliveCor Coreline Soft Co.
Description A cloud-based Software as a Medical Device (SaMD) that provides instant, accurate QT and QTc interval measurements from AliveCor 6-Lead ECGs, enabling healthcare professionals to assess cardiac safety and inform medication prescribing decisions. Coreline Soft's AVIEW LCS is an AI-powered solution for the detection and analysis of lung nodules. The AVIEW LCS Plus platform provides integrated, fully automatic analysis of lung cancer, COPD, and coronary artery calcification from a single low-dose CT scan, enhancing diagnostic accuracy and streamlining radiology workflows.
Primary Function Instant, accurate QT interval measurement for enhanced cardiac safety and informed clinical decision-making. AI-Powered Lung Cancer Screening & Cardiopulmonary Assessment
Key Features (Cardiac) Measures QT and QTc intervals (Bazett's and Fridericia's formulas), Provides instant QT measurements (as InstantQT) Coronary Artery Calcification (CAC) scoring (Agatston, volume, mass)
Key Features (Other) Analyzes ECGs from AliveCor 6-Lead ambulatory ECG devices (e.g., KardiaMobile 6L), Prescription (Rx) use only, for qualified healthcare professionals, Utilizes AI and deep neural networks for ECG analysis, Integrates with KardiaStation app and KardiaPro portal, API available for integration with EHR, SDK, CRM, EDC, and PSP platforms Automated lung nodule detection and analysis, Lung-RADS classification and reporting, Nodule volume quantification and 3D segmentation, Emphysema quantification (LAA index), Automated comparison of nodules in follow-up CT scans, Comprehensive, automated report generation, Integration with PACS/RIS and third-party platforms
Specialties Cardiology, Emergency Medicine, Internal Medicine Cardiology, Oncology, Pulmonology, Radiology

Videos

Demos, reviews, and walkthroughs featuring AliveCor QT Service and AVIEW LCS.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

AliveCor QT Service is a cloud-based Software as a Medical Device (SaMD) focused on providing instant, accurate QT and QTc interval measurements from AliveCor 6-Lead ECGs to assess cardiac safety and inform medication prescribing decisions. AVIEW LCS is an AI-powered solution for the detection and analysis of lung nodules, lung cancer screening, COPD, and coronary artery calcification from low-dose CT scans, enhancing diagnostic accuracy and streamlining radiology workflows.
AliveCor QT Service analyzes ECGs specifically from AliveCor 6-Lead ambulatory ECG devices. AVIEW LCS analyzes data from low-dose CT scans to assess lung cancer, COPD, and coronary artery calcification.
AliveCor QT Service provides instant QT and QTc interval measurements using Bazett's and Fridericia's formulas. AVIEW LCS offers automated lung nodule detection and analysis, Lung-RADS classification, nodule volume quantification, 3D segmentation, emphysema quantification (LAA index), and Coronary Artery Calcification (CAC) scoring (Agatston, volume, mass).
AliveCor QT Service integrates with the KardiaStation app and KardiaPro portal, and offers an API for integration with EHR, SDK, CRM, EDC, and PSP platforms. AVIEW LCS integrates with PACS/RIS and other third-party platforms.
AliveCor QT Service is primarily for Cardiology, Emergency Medicine, and Internal Medicine, focusing on cardiac safety and medication prescribing decisions. AVIEW LCS targets Cardiology, Oncology, Pulmonology, and Radiology, offering comprehensive cardiopulmonary assessment.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.